RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Network meta-analysis accurately predicted the outcome of a subsequent randomised trial comparing once weekly dulaglutide 1.5 mg and once daily liraglutide 1.8 mg.

Network meta-analysis accurately predicted the outcome of a subsequent randomised trial comparing once weekly dulaglutide 1.5 mg and once daily liraglutide 1.8 mg.

Add to Collection
2016 Mar Systematic Review and Meta Analysis Fist_Author_Year_PM

Full Author : ['Fahrbach, J L', 'Fu, H', 'Shurzinske, L', 'Skrivanek, Z', 'Martin, S']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2016
Cited by : Not Available

BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are an established treatment for people with type 2 diabetes (T2D). We aimed to indirectly compare two GLP-1 receptor agonists, once weekly dulaglutide 1.5 mg and once daily liraglutide 1.8 mg,.....

Keywords : ["subsequent randomised trial compare", "network metaanalysis accurately predict", "weekly dulaglutide mg", "daily liraglutide mg", "outcome"]